Foyston Gordon & Payne Inc lowered its stake in UnitedHealth Group Incorporated (NYSE:UNH – Get Rating) by 3.2% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 43,494 shares of the healthcare conglomerate’s stock after selling 1,455 shares during the period. UnitedHealth Group makes up approximately 5.1% of Foyston Gordon & Payne Inc’s portfolio, making the stock its 4th biggest holding. Foyston Gordon & Payne Inc’s holdings in UnitedHealth Group were worth $21,840,000 at the end of the most recent reporting period.
Several other large investors also recently added to or reduced their stakes in UNH. Assetmark Inc. boosted its stake in shares of UnitedHealth Group by 5.2% in the third quarter. Assetmark Inc. now owns 213,353 shares of the healthcare conglomerate’s stock valued at $83,366,000 after buying an additional 10,463 shares in the last quarter. Lincoln National Corp boosted its position in UnitedHealth Group by 15.1% during the fourth quarter. Lincoln National Corp now owns 8,951 shares of the healthcare conglomerate’s stock worth $4,495,000 after purchasing an additional 1,174 shares in the last quarter. Dohj LLC boosted its position in UnitedHealth Group by 4.2% during the third quarter. Dohj LLC now owns 6,446 shares of the healthcare conglomerate’s stock worth $2,968,000 after purchasing an additional 257 shares in the last quarter. YorkBridge Wealth Partners LLC lifted its position in shares of UnitedHealth Group by 1.8% in the fourth quarter. YorkBridge Wealth Partners LLC now owns 15,296 shares of the healthcare conglomerate’s stock valued at $7,681,000 after acquiring an additional 272 shares in the last quarter. Finally, Alexandria Capital LLC lifted its position in shares of UnitedHealth Group by 3.5% in the third quarter. Alexandria Capital LLC now owns 17,100 shares of the healthcare conglomerate’s stock valued at $6,682,000 after acquiring an additional 584 shares in the last quarter. 87.48% of the stock is currently owned by institutional investors and hedge funds.
UNH stock traded up $7.17 during trading hours on Thursday, reaching $478.55. The stock had a trading volume of 3,812,571 shares, compared to its average volume of 3,347,439. The company has a debt-to-equity ratio of 0.54, a current ratio of 0.78 and a quick ratio of 0.78. The stock has a 50-day simple moving average of $511.16 and a 200 day simple moving average of $485.04. The stock has a market capitalization of $448.96 billion, a PE ratio of 25.99, a price-to-earnings-growth ratio of 1.52 and a beta of 0.83. UnitedHealth Group Incorporated has a fifty-two week low of $383.12 and a fifty-two week high of $553.29.
Several equities analysts recently commented on the company. Raymond James upped their target price on UnitedHealth Group from $540.00 to $620.00 and gave the company a “strong-buy” rating in a research note on Tuesday, April 19th. Cowen upped their target price on UnitedHealth Group from $512.00 to $596.00 in a research note on Monday, April 18th. BMO Capital Markets raised their price objective on UnitedHealth Group from $510.00 to $600.00 and gave the stock a “market perform” rating in a report on Tuesday, April 19th. StockNews.com began coverage on shares of UnitedHealth Group in a research note on Thursday, March 31st. They set a “strong-buy” rating for the company. Finally, SVB Leerink upped their target price on shares of UnitedHealth Group from $550.00 to $600.00 and gave the company an “outperform” rating in a research note on Tuesday, April 19th. Two investment analysts have rated the stock with a hold rating, twenty have issued a buy rating and two have given a strong buy rating to the company’s stock. Based on data from MarketBeat.com, UnitedHealth Group currently has an average rating of “Buy” and a consensus target price of $550.17.
In related news, Director Richard T. Burke sold 4,000 shares of the company’s stock in a transaction dated Tuesday, March 22nd. The shares were sold at an average price of $511.14, for a total value of $2,044,560.00. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Also, Director Richard T. Burke sold 6,000 shares of the stock in a transaction that occurred on Friday, February 25th. The stock was sold at an average price of $470.38, for a total value of $2,822,280.00. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 15,500 shares of company stock valued at $7,626,365. Company insiders own 0.55% of the company’s stock.
UnitedHealth Group Company Profile (Get Rating)
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage and well-being services to individuals age 50 and older addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; Medicaid plans, children's health insurance and health care programs; health and dental benefits; and hospital and clinical services.
- Get a free copy of the StockNews.com research report on UnitedHealth Group (UNH)
- The Institutional Tide Has Turned For Cisco Systems
- Don’t Bet On Cheaper Oil, Not Yet Anway
- Can Nvidia Bounce Back
- A Reversal In The S&P 500 Is Confirmed
- MarketBeat Podcast: Options Trading As Easy As Trading Stocks
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.